These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 22213221)
1. Cardiac and skeletal muscle expression of mutant β-myosin heavy chains, degree of functional impairment and phenotypic heterogeneity in hypertrophic cardiomyopathy. Di Domenico M; Casadonte R; Ricci P; Santini M; Frati G; Rizzo A; Carratelli CR; Lamberti M; Parrotta E; Quaresima B; Faniello CM; Costanzo F; Cuda G J Cell Physiol; 2012 Oct; 227(10):3471-6. PubMed ID: 22213221 [TBL] [Abstract][Full Text] [Related]
3. Isometric tension and mutant myosin heavy chain content in single skeletal myofibers from hypertrophic cardiomyopathy patients. Malinchik S; Cuda G; Podolsky RJ; Horowits R J Mol Cell Cardiol; 1997 Feb; 29(2):667-76. PubMed ID: 9140824 [TBL] [Abstract][Full Text] [Related]
4. Human homozygous R403W mutant cardiac myosin presents disproportionate enhancement of mechanical and enzymatic properties. Keller DI; Coirault C; Rau T; Cheav T; Weyand M; Amann K; Lecarpentier Y; Richard P; Eschenhagen T; Carrier L J Mol Cell Cardiol; 2004 Mar; 36(3):355-62. PubMed ID: 15010274 [TBL] [Abstract][Full Text] [Related]
5. Mutation of Arg723Gly in beta-myosin heavy chain gene in five Chinese families with hypertrophic cardiomyopathy. Yang JH; Zheng DD; Dong NZ; Yang XJ; Song JP; Jiang TB; Cheng XJ; Li HX; Zhou BY; Zhao CM; Jiang WP Chin Med J (Engl); 2006 Nov; 119(21):1785-9. PubMed ID: 17097032 [TBL] [Abstract][Full Text] [Related]
6. Morphological and functional alterations in ventricular myocytes from male transgenic mice with hypertrophic cardiomyopathy. Olsson MC; Palmer BM; Stauffer BL; Leinwand LA; Moore RL Circ Res; 2004 Feb; 94(2):201-7. PubMed ID: 14670849 [TBL] [Abstract][Full Text] [Related]
8. Heterologous expression of wild-type and mutant beta-cardiac myosin changes the contractile kinetics of cultured mouse myotubes. Miller G; Maycock J; White E; Peckham M; Calaghan S J Physiol; 2003 Apr; 548(Pt 1):167-74. PubMed ID: 12576501 [TBL] [Abstract][Full Text] [Related]
10. Beta-myosin heavy chain gene mutations in familial hypertrophic cardiomyopathy: the usual suspect? McNally EM Circ Res; 2002 Feb; 90(3):246-7. PubMed ID: 11861410 [No Abstract] [Full Text] [Related]
11. The left and right ventricle of a patient with a R723G mutation of the beta-myosin heavy chain and severe hypertrophic cardiomyopathy show no differences in the expression of myosin mRNA. Borchert B; Tripathi S; Francino A; Navarro-Lopez F; Kraft T Cardiol J; 2010; 17(5):518-22. PubMed ID: 20865685 [TBL] [Abstract][Full Text] [Related]
12. One third of Danish hypertrophic cardiomyopathy patients with MYH7 mutations have mutations [corrected] in MYH7 rod region. Hougs L; Havndrup O; Bundgaard H; Køber L; Vuust J; Larsen LA; Christiansen M; Andersen PS Eur J Hum Genet; 2005 Feb; 13(2):161-5. PubMed ID: 15483641 [TBL] [Abstract][Full Text] [Related]
13. A novel beta-myosin heavy chain gene mutation, p.Met531Arg, identified in isolated left ventricular non-compaction in humans, results in left ventricular hypertrophy that progresses to dilation in a mouse model. Kaneda T; Naruse C; Kawashima A; Fujino N; Oshima T; Namura M; Nunoda S; Mori S; Konno T; Ino H; Yamagishi M; Asano M Clin Sci (Lond); 2008 Mar; 114(6):431-40. PubMed ID: 17956225 [TBL] [Abstract][Full Text] [Related]
14. Three novel mutations in exon 21 encoding beta-cardiac myosin heavy chain. Moric E; Mazurek U; Połońska J; Domal-Kwiatkowska D; Smolik S; Kozakiewicz K; Tendera M; Wilczok T J Appl Genet; 2003; 44(1):103-9. PubMed ID: 12590187 [TBL] [Abstract][Full Text] [Related]
15. Preclinical diagnosis of familial hypertrophic cardiomyopathy by genetic analysis of blood lymphocytes. Rosenzweig A; Watkins H; Hwang DS; Miri M; McKenna W; Traill TA; Seidman JG; Seidman CE N Engl J Med; 1991 Dec; 325(25):1753-60. PubMed ID: 1944483 [TBL] [Abstract][Full Text] [Related]
16. Missense mutation of the beta-cardiac myosin heavy-chain gene in hypertrophic cardiomyopathy. Arai S; Matsuoka R; Hirayama K; Sakurai H; Tamura M; Ozawa T; Kimura M; Imamura S; Furutani Y; Joh-o K Am J Med Genet; 1995 Sep; 58(3):267-76. PubMed ID: 8533830 [TBL] [Abstract][Full Text] [Related]
17. Mutations in the motor domain modulate myosin activity and myofibril organization. Wang Q; Moncman CL; Winkelmann DA J Cell Sci; 2003 Oct; 116(Pt 20):4227-38. PubMed ID: 12953063 [TBL] [Abstract][Full Text] [Related]
18. Severe heart failure and early mortality in a double-mutation mouse model of familial hypertrophic cardiomyopathy. Tsoutsman T; Kelly M; Ng DC; Tan JE; Tu E; Lam L; Bogoyevitch MA; Seidman CE; Seidman JG; Semsarian C Circulation; 2008 Apr; 117(14):1820-31. PubMed ID: 18362229 [TBL] [Abstract][Full Text] [Related]
19. Functional effects of the hypertrophic cardiomyopathy R403Q mutation are different in an alpha- or beta-myosin heavy chain backbone. Lowey S; Lesko LM; Rovner AS; Hodges AR; White SL; Low RB; Rincon M; Gulick J; Robbins J J Biol Chem; 2008 Jul; 283(29):20579-89. PubMed ID: 18480046 [TBL] [Abstract][Full Text] [Related]
20. Skeletal muscle expression and abnormal function of beta-myosin in hypertrophic cardiomyopathy. Cuda G; Fananapazir L; Zhu WS; Sellers JR; Epstein ND J Clin Invest; 1993 Jun; 91(6):2861-5. PubMed ID: 8514894 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]